

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.09550754 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.09550754 |
| 3 | cholesterol biosynthetic process (GO:0006695) | 6.76999463 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.72558050 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 6.72558050 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.42291538 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.02112370 |
| 8 | sterol biosynthetic process (GO:0016126) | 6.00104288 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.80942210 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.80942210 |
| 11 | tryptophan catabolic process (GO:0006569) | 5.80942210 |
| 12 | alpha-linolenic acid metabolic process (GO:0036109) | 5.74942112 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.71391140 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.61044270 |
| 15 | urea metabolic process (GO:0019627) | 5.50930481 |
| 16 | urea cycle (GO:0000050) | 5.50930481 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.50251769 |
| 18 | high-density lipoprotein particle remodeling (GO:0034375) | 5.39996475 |
| 19 | nuclear pore complex assembly (GO:0051292) | 5.31971868 |
| 20 | glyoxylate metabolic process (GO:0046487) | 5.29726071 |
| 21 | protein carboxylation (GO:0018214) | 5.20209750 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.20209750 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 5.19491388 |
| 24 | cysteine metabolic process (GO:0006534) | 5.16113441 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 5.04580418 |
| 26 | nitrogen cycle metabolic process (GO:0071941) | 5.02410537 |
| 27 | regulation of fibrinolysis (GO:0051917) | 4.95668277 |
| 28 | regulation of protein activation cascade (GO:2000257) | 4.94125660 |
| 29 | negative regulation of cholesterol transport (GO:0032375) | 4.90580837 |
| 30 | negative regulation of sterol transport (GO:0032372) | 4.90580837 |
| 31 | homocysteine metabolic process (GO:0050667) | 4.89229162 |
| 32 | bile acid metabolic process (GO:0008206) | 4.89196203 |
| 33 | complement activation, alternative pathway (GO:0006957) | 4.83707631 |
| 34 | nuclear pore organization (GO:0006999) | 4.82980919 |
| 35 | isoprenoid biosynthetic process (GO:0008299) | 4.76011226 |
| 36 | phospholipid efflux (GO:0033700) | 4.68043089 |
| 37 | aromatic amino acid family metabolic process (GO:0009072) | 4.67149772 |
| 38 | bile acid and bile salt transport (GO:0015721) | 4.65216509 |
| 39 | reverse cholesterol transport (GO:0043691) | 4.64082095 |
| 40 | regulation of triglyceride catabolic process (GO:0010896) | 4.62360427 |
| 41 | cellular glucuronidation (GO:0052695) | 4.60473455 |
| 42 | regulation of complement activation (GO:0030449) | 4.60444975 |
| 43 | regulation of cholesterol esterification (GO:0010872) | 4.56852521 |
| 44 | serine family amino acid catabolic process (GO:0009071) | 4.56522204 |
| 45 | plasma lipoprotein particle remodeling (GO:0034369) | 4.55550336 |
| 46 | protein-lipid complex remodeling (GO:0034368) | 4.55550336 |
| 47 | macromolecular complex remodeling (GO:0034367) | 4.55550336 |
| 48 | tyrosine metabolic process (GO:0006570) | 4.47682716 |
| 49 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.45235129 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.42097445 |
| 51 | triglyceride homeostasis (GO:0070328) | 4.42097445 |
| 52 | amino-acid betaine metabolic process (GO:0006577) | 4.40503026 |
| 53 | regulation of cholesterol homeostasis (GO:2000188) | 4.38971181 |
| 54 | intestinal cholesterol absorption (GO:0030299) | 4.36268585 |
| 55 | drug catabolic process (GO:0042737) | 4.34103644 |
| 56 | cellular ketone body metabolic process (GO:0046950) | 4.31501215 |
| 57 | plasma lipoprotein particle clearance (GO:0034381) | 4.22378363 |
| 58 | plasma lipoprotein particle assembly (GO:0034377) | 4.22259098 |
| 59 | lysine metabolic process (GO:0006553) | 4.22098390 |
| 60 | lysine catabolic process (GO:0006554) | 4.22098390 |
| 61 | indolalkylamine metabolic process (GO:0006586) | 4.20352952 |
| 62 | glycine metabolic process (GO:0006544) | 4.19437001 |
| 63 | cholesterol efflux (GO:0033344) | 4.18705849 |
| 64 | alpha-amino acid catabolic process (GO:1901606) | 4.14661720 |
| 65 | response to lipoprotein particle (GO:0055094) | 4.07650905 |
| 66 | glucuronate metabolic process (GO:0019585) | 4.07547082 |
| 67 | uronic acid metabolic process (GO:0006063) | 4.07547082 |
| 68 | imidazole-containing compound metabolic process (GO:0052803) | 4.07143030 |
| 69 | ethanol oxidation (GO:0006069) | 4.02839647 |
| 70 | benzene-containing compound metabolic process (GO:0042537) | 4.00644715 |
| 71 | flavonoid metabolic process (GO:0009812) | 3.98629078 |
| 72 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.98318353 |
| 73 | amine catabolic process (GO:0009310) | 3.97985403 |
| 74 | cellular biogenic amine catabolic process (GO:0042402) | 3.97985403 |
| 75 | serine family amino acid metabolic process (GO:0009069) | 3.96982771 |
| 76 | serine family amino acid biosynthetic process (GO:0009070) | 3.95915763 |
| 77 | fibrinolysis (GO:0042730) | 3.91884198 |
| 78 | cholesterol homeostasis (GO:0042632) | 3.88755860 |
| 79 | glutamate metabolic process (GO:0006536) | 3.85614143 |
| 80 | sterol homeostasis (GO:0055092) | 3.84841224 |
| 81 | blood coagulation, intrinsic pathway (GO:0007597) | 3.84329293 |
| 82 | arginine metabolic process (GO:0006525) | 3.84083056 |
| 83 | sister chromatid segregation (GO:0000819) | 3.83293784 |
| 84 | protein-lipid complex assembly (GO:0065005) | 3.79447360 |
| 85 | cellular amino acid catabolic process (GO:0009063) | 3.78077556 |
| 86 | coenzyme catabolic process (GO:0009109) | 3.76437114 |
| 87 | regulation of bile acid biosynthetic process (GO:0070857) | 3.74194239 |
| 88 | cellular modified amino acid catabolic process (GO:0042219) | 3.72083634 |
| 89 | ketone body metabolic process (GO:1902224) | 3.71281079 |
| 90 | lipoprotein metabolic process (GO:0042157) | 3.71097761 |
| 91 | pore complex assembly (GO:0046931) | 3.70769369 |
| 92 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 3.69907636 |
| 93 | regulation of sister chromatid cohesion (GO:0007063) | 3.69478381 |
| 94 | short-chain fatty acid metabolic process (GO:0046459) | 3.66557010 |
| 95 | protein localization to kinetochore (GO:0034501) | 3.66135876 |
| 96 | phospholipid homeostasis (GO:0055091) | 3.66027551 |
| 97 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.65410523 |
| 98 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.65410523 |
| 99 | low-density lipoprotein particle remodeling (GO:0034374) | 3.64938017 |
| 100 | positive regulation of lipid catabolic process (GO:0050996) | 3.64460840 |
| 101 | regulation of centriole replication (GO:0046599) | 3.61867067 |
| 102 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.61063037 |
| 103 | plasma lipoprotein particle organization (GO:0071827) | 3.59917154 |
| 104 | exogenous drug catabolic process (GO:0042738) | 3.59750740 |
| 105 | acetyl-CoA metabolic process (GO:0006084) | 3.59296507 |
| 106 | mitotic sister chromatid segregation (GO:0000070) | 3.58238682 |
| 107 | drug transmembrane transport (GO:0006855) | 3.57102075 |
| 108 | aldehyde catabolic process (GO:0046185) | 3.53344281 |
| 109 | intestinal absorption (GO:0050892) | 3.53109779 |
| 110 | response to nitrosative stress (GO:0051409) | 3.50154617 |
| 111 | urate metabolic process (GO:0046415) | 3.46582546 |
| 112 | negative regulation of lipase activity (GO:0060192) | 3.46469987 |
| 113 | drug metabolic process (GO:0017144) | 3.45529627 |
| 114 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.42141484 |
| 115 | response to follicle-stimulating hormone (GO:0032354) | 3.41191488 |
| 116 | protein localization to chromosome, centromeric region (GO:0071459) | 3.37498423 |
| 117 | layer formation in cerebral cortex (GO:0021819) | 3.36587745 |
| 118 | DNA double-strand break processing (GO:0000729) | 3.35962501 |
| 119 | mitotic sister chromatid cohesion (GO:0007064) | 3.28969027 |
| 120 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.26727354 |
| 121 | acrosome assembly (GO:0001675) | 3.22379327 |
| 122 | mitotic chromosome condensation (GO:0007076) | 3.12813039 |
| 123 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.08488709 |
| 124 | spindle checkpoint (GO:0031577) | 3.05498923 |
| 125 | paraxial mesoderm development (GO:0048339) | 3.03422851 |
| 126 | metaphase plate congression (GO:0051310) | 3.02351001 |
| 127 | mitotic metaphase plate congression (GO:0007080) | 3.00089603 |
| 128 | mitotic spindle checkpoint (GO:0071174) | 2.98438209 |
| 129 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.98330208 |
| 130 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.98330208 |
| 131 | DNA topological change (GO:0006265) | 2.97775957 |
| 132 | CENP-A containing nucleosome assembly (GO:0034080) | 2.96848086 |
| 133 | mitotic G2/M transition checkpoint (GO:0044818) | 2.96145087 |
| 134 | COPII vesicle coating (GO:0048208) | 2.93840986 |
| 135 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.89067059 |
| 136 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.89067059 |
| 137 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.89067059 |
| 138 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.89067059 |
| 139 | negative regulation of sister chromatid segregation (GO:0033046) | 2.89067059 |
| 140 | DNA unwinding involved in DNA replication (GO:0006268) | 2.88805079 |
| 141 | negative regulation of chromosome segregation (GO:0051985) | 2.88560409 |
| 142 | regulation of chromosome segregation (GO:0051983) | 2.87476894 |
| 143 | midgut development (GO:0007494) | 2.85969571 |
| 144 | chromatin remodeling at centromere (GO:0031055) | 2.85964689 |
| 145 | establishment of integrated proviral latency (GO:0075713) | 2.85081289 |
| 146 | establishment of chromosome localization (GO:0051303) | 2.82515627 |
| 147 | regulation of sister chromatid segregation (GO:0033045) | 2.82157753 |
| 148 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.82157753 |
| 149 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.82157753 |
| 150 | regulation of DNA endoreduplication (GO:0032875) | 2.79392503 |
| 151 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.79252301 |
| 152 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.78640408 |
| 153 | spermatid nucleus differentiation (GO:0007289) | 2.77145461 |
| 154 | non-recombinational repair (GO:0000726) | 2.76852128 |
| 155 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.76852128 |
| 156 | kinetochore organization (GO:0051383) | 2.76541752 |
| 157 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 2.76469581 |
| 158 | mitotic spindle organization (GO:0007052) | 2.70107708 |
| 159 | mitotic spindle assembly checkpoint (GO:0007094) | 2.69982559 |
| 160 | spindle assembly checkpoint (GO:0071173) | 2.67306525 |
| 161 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.67295999 |
| 162 | regulation of development, heterochronic (GO:0040034) | 2.65684017 |
| 163 | glycolytic process (GO:0006096) | 2.64737671 |
| 164 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.63479303 |
| 165 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.63479303 |
| 166 | DNA ligation (GO:0006266) | 2.59614026 |
| 167 | embryonic foregut morphogenesis (GO:0048617) | 2.59112221 |
| 168 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.58395435 |
| 169 | morphogenesis of an epithelial sheet (GO:0002011) | 2.57023551 |
| 170 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.56738272 |
| 171 | regulation of centrosome cycle (GO:0046605) | 2.55406560 |
| 172 | regulation of centrosome duplication (GO:0010824) | 2.55364438 |
| 173 | Golgi transport vesicle coating (GO:0048200) | 2.52952270 |
| 174 | COPI coating of Golgi vesicle (GO:0048205) | 2.52952270 |
| 175 | short-term memory (GO:0007614) | 2.49232708 |
| 176 | ATP-dependent chromatin remodeling (GO:0043044) | 2.48492763 |
| 177 | protein localization to chromosome (GO:0034502) | 2.47620883 |
| 178 | regulation of RNA export from nucleus (GO:0046831) | 2.47479652 |
| 179 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.47168214 |
| 180 | mitotic nuclear envelope disassembly (GO:0007077) | 2.47154187 |
| 181 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 2.46893301 |
| 182 | dorsal/ventral axis specification (GO:0009950) | 2.46157811 |
| 183 | pre-miRNA processing (GO:0031054) | 2.45052286 |
| 184 | mitotic cytokinesis (GO:0000281) | 2.44595583 |
| 185 | histone exchange (GO:0043486) | 2.44190808 |
| 186 | negative regulation of DNA recombination (GO:0045910) | 2.44014182 |
| 187 | regulation of Rac protein signal transduction (GO:0035020) | 2.43610382 |
| 188 | L-serine metabolic process (GO:0006563) | 2.42809893 |
| 189 | cytoskeleton-dependent cytokinesis (GO:0061640) | 2.42673201 |
| 190 | cell adhesion mediated by integrin (GO:0033627) | 2.42648227 |
| 191 | DNA replication-independent nucleosome organization (GO:0034724) | 2.42260754 |
| 192 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.42260754 |
| 193 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.42232946 |
| 194 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.42232946 |
| 195 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.42232946 |
| 196 | membrane disassembly (GO:0030397) | 2.40743123 |
| 197 | nuclear envelope disassembly (GO:0051081) | 2.40743123 |
| 198 | gastrulation with mouth forming second (GO:0001702) | 2.40591708 |
| 199 | DNA duplex unwinding (GO:0032508) | 2.39617771 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.81737645 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.80165587 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.31732369 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.15816378 |
| 5 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 4.85091269 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.74319817 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.56474726 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.37633203 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.18477884 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.65125931 |
| 11 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.58918804 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.57362850 |
| 13 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.14748714 |
| 14 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.13477439 |
| 15 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.84064014 |
| 16 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.80657782 |
| 17 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.59958376 |
| 18 | * WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.47266744 |
| 19 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.43274156 |
| 20 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.33067874 |
| 21 | FUS_26573619_Chip-Seq_HEK293_Human | 2.28457743 |
| 22 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.24465485 |
| 23 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.22805710 |
| 24 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.09990565 |
| 25 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.08589757 |
| 26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.07473786 |
| 27 | EWS_26573619_Chip-Seq_HEK293_Human | 2.05493772 |
| 28 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.04067945 |
| 29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.03179701 |
| 30 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.01702142 |
| 31 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.2359118 |
| 32 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.94774412 |
| 33 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.84244680 |
| 34 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.79645859 |
| 35 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.74979178 |
| 36 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.73504121 |
| 37 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.70358139 |
| 38 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.69762526 |
| 39 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.69427112 |
| 40 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.69220688 |
| 41 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.68188035 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.67612431 |
| 43 | P300_19829295_ChIP-Seq_ESCs_Human | 1.66095311 |
| 44 | VDR_22108803_ChIP-Seq_LS180_Human | 1.62388452 |
| 45 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.60320443 |
| 46 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.59820003 |
| 47 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.59371600 |
| 48 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.56878481 |
| 49 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.56570106 |
| 50 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.55906592 |
| 51 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.55197112 |
| 52 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.53397732 |
| 53 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51374057 |
| 54 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.51072412 |
| 55 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.46928249 |
| 56 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.46890777 |
| 57 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.45180590 |
| 58 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.43898172 |
| 59 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.43251763 |
| 60 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.41036552 |
| 61 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.39146473 |
| 62 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.38116480 |
| 63 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.37375793 |
| 64 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.33833687 |
| 65 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.33832141 |
| 66 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.31507313 |
| 67 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.30631056 |
| 68 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.30455770 |
| 69 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.29995793 |
| 70 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.29563265 |
| 71 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.26593421 |
| 72 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.24439075 |
| 73 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.23631427 |
| 74 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.23070258 |
| 75 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.22648846 |
| 76 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.21287509 |
| 77 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.20611046 |
| 78 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.20158287 |
| 79 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.18116561 |
| 80 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.17656291 |
| 81 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.17620157 |
| 82 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.17445697 |
| 83 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.17052761 |
| 84 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.16697686 |
| 85 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.16245840 |
| 86 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.15790304 |
| 87 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.14902347 |
| 88 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14811735 |
| 89 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.14364414 |
| 90 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.14023993 |
| 91 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.13307533 |
| 92 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.12140334 |
| 93 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.11429808 |
| 94 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.11321390 |
| 95 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.09739188 |
| 96 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.09559331 |
| 97 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.09363883 |
| 98 | STAT3_23295773_ChIP-Seq_U87_Human | 1.09312161 |
| 99 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.09045491 |
| 100 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.08879652 |
| 101 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.08879652 |
| 102 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.08879652 |
| 103 | * KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.08872015 |
| 104 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.07040007 |
| 105 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.06510397 |
| 106 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.05164818 |
| 107 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04793624 |
| 108 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.04648083 |
| 109 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.03875490 |
| 110 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.03664478 |
| 111 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.03420746 |
| 112 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03382496 |
| 113 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03301078 |
| 114 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.02971180 |
| 115 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.02663596 |
| 116 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 1.02614349 |
| 117 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01030229 |
| 118 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99611556 |
| 119 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.99488729 |
| 120 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.99407693 |
| 121 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.99220436 |
| 122 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.99190153 |
| 123 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.99024132 |
| 124 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98357494 |
| 125 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.98168240 |
| 126 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97962860 |
| 127 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.97804552 |
| 128 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.97576195 |
| 129 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.96363546 |
| 130 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.95981089 |
| 131 | * TP53_16413492_ChIP-PET_HCT116_Human | 0.95573361 |
| 132 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.95089566 |
| 133 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91166689 |
| 134 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88035760 |
| 135 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.85161677 |
| 136 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.84815680 |
| 137 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.84050758 |
| 138 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.83795703 |
| 139 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.83509761 |
| 140 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.82741325 |
| 141 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.82710772 |
| 142 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.81858579 |
| 143 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79625230 |
| 144 | GATA2_19941826_ChIP-Seq_K562_Human | 0.79526500 |
| 145 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79040913 |
| 146 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.76744330 |
| 147 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76478964 |
| 148 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.75034774 |
| 149 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.75034774 |
| 150 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.73955291 |
| 151 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.72235673 |
| 152 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.72188841 |
| 153 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.72122310 |
| 154 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.70983662 |
| 155 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.70802791 |
| 156 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69998983 |
| 157 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.67517059 |
| 158 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.66821108 |
| 159 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.62345429 |
| 160 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.61967776 |
| 161 | ATF3_27146783_Chip-Seq_COLON_Human | 0.61959378 |
| 162 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.61682865 |
| 163 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.60158332 |
| 164 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.59702522 |
| 165 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.58688892 |
| 166 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.58377662 |
| 167 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.58203598 |
| 168 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.57507594 |
| 169 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.56931672 |
| 170 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.56177052 |
| 171 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.55979208 |
| 172 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.55178581 |
| 173 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.55027062 |
| 174 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.54484526 |
| 175 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.54355474 |
| 176 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.52685525 |
| 177 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.51989520 |
| 178 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.51989520 |
| 179 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.51105368 |
| 180 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.51039541 |
| 181 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.50034269 |
| 182 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.48812949 |
| 183 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.48709814 |
| 184 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.48202385 |
| 185 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.46622573 |
| 186 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.44142527 |
| 187 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.44138206 |
| 188 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.43888442 |
| 189 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.43802770 |
| 190 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.42209721 |
| 191 | CBP_21632823_ChIP-Seq_H3396_Human | 0.41610576 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.14158164 |
| 2 | MP0005360_urolithiasis | 7.57877329 |
| 3 | * MP0005085_abnormal_gallbladder_physiolo | 5.90727415 |
| 4 | MP0005365_abnormal_bile_salt | 5.46000830 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.81154815 |
| 6 | MP0003252_abnormal_bile_duct | 3.75277319 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.70384089 |
| 8 | MP0005083_abnormal_biliary_tract | 3.22391162 |
| 9 | * MP0010329_abnormal_lipoprotein_level | 3.19957004 |
| 10 | MP0009840_abnormal_foam_cell | 3.15693563 |
| 11 | MP0003890_abnormal_embryonic-extraembry | 3.09099344 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.84850657 |
| 13 | MP0004272_abnormal_basement_membrane | 2.82619791 |
| 14 | MP0003122_maternal_imprinting | 2.67501535 |
| 15 | MP0003567_abnormal_fetal_cardiomyocyte | 2.61575668 |
| 16 | MP0010094_abnormal_chromosome_stability | 2.51136086 |
| 17 | MP0004957_abnormal_blastocyst_morpholog | 2.46524082 |
| 18 | MP0008057_abnormal_DNA_replication | 2.38028791 |
| 19 | MP0003195_calcinosis | 2.29483758 |
| 20 | MP0005332_abnormal_amino_acid | 2.28877402 |
| 21 | MP0003941_abnormal_skin_development | 2.25723180 |
| 22 | MP0005248_abnormal_Harderian_gland | 2.22161724 |
| 23 | MP0003077_abnormal_cell_cycle | 2.13632725 |
| 24 | MP0008932_abnormal_embryonic_tissue | 2.13148037 |
| 25 | MP0000609_abnormal_liver_physiology | 2.02021933 |
| 26 | MP0003868_abnormal_feces_composition | 2.00958918 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 1.99920721 |
| 28 | MP0004019_abnormal_vitamin_homeostasis | 1.98968057 |
| 29 | MP0003111_abnormal_nucleus_morphology | 1.98518602 |
| 30 | MP0000778_abnormal_nervous_system | 1.91042765 |
| 31 | MP0002009_preneoplasia | 1.90106583 |
| 32 | MP0003937_abnormal_limbs/digits/tail_de | 1.89320356 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.88128830 |
| 34 | MP0000537_abnormal_urethra_morphology | 1.86592881 |
| 35 | MP0009697_abnormal_copulation | 1.82895076 |
| 36 | * MP0002118_abnormal_lipid_homeostasis | 1.82504121 |
| 37 | MP0002138_abnormal_hepatobiliary_system | 1.77529355 |
| 38 | MP0001293_anophthalmia | 1.75413499 |
| 39 | MP0005451_abnormal_body_composition | 1.70635857 |
| 40 | MP0006072_abnormal_retinal_apoptosis | 1.66813942 |
| 41 | MP0003385_abnormal_body_wall | 1.66666748 |
| 42 | MP0002697_abnormal_eye_size | 1.66616250 |
| 43 | MP0003693_abnormal_embryo_hatching | 1.62233229 |
| 44 | MP0005319_abnormal_enzyme/_coenzyme | 1.60769686 |
| 45 | MP0002938_white_spotting | 1.54487380 |
| 46 | MP0003221_abnormal_cardiomyocyte_apopto | 1.53935313 |
| 47 | MP0003984_embryonic_growth_retardation | 1.52424643 |
| 48 | MP0008058_abnormal_DNA_repair | 1.52388189 |
| 49 | MP0001672_abnormal_embryogenesis/_devel | 1.51506856 |
| 50 | MP0005380_embryogenesis_phenotype | 1.51506856 |
| 51 | MP0001177_atelectasis | 1.51475016 |
| 52 | MP0002233_abnormal_nose_morphology | 1.51195835 |
| 53 | MP0001286_abnormal_eye_development | 1.49808919 |
| 54 | MP0008007_abnormal_cellular_replicative | 1.48784198 |
| 55 | MP0010234_abnormal_vibrissa_follicle | 1.48748809 |
| 56 | MP0002088_abnormal_embryonic_growth/wei | 1.45635643 |
| 57 | MP0001529_abnormal_vocalization | 1.45626382 |
| 58 | MP0000569_abnormal_digit_pigmentation | 1.44895420 |
| 59 | MP0002796_impaired_skin_barrier | 1.43720548 |
| 60 | MP0003121_genomic_imprinting | 1.40340710 |
| 61 | MP0001984_abnormal_olfaction | 1.40167855 |
| 62 | MP0001730_embryonic_growth_arrest | 1.38691490 |
| 63 | MP0002084_abnormal_developmental_patter | 1.38688193 |
| 64 | MP0010368_abnormal_lymphatic_system | 1.38018162 |
| 65 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.33087869 |
| 66 | MP0005394_taste/olfaction_phenotype | 1.32199263 |
| 67 | MP0005499_abnormal_olfactory_system | 1.32199263 |
| 68 | MP0003755_abnormal_palate_morphology | 1.30509966 |
| 69 | MP0001764_abnormal_homeostasis | 1.29772182 |
| 70 | MP0001299_abnormal_eye_distance/ | 1.29712584 |
| 71 | MP0001697_abnormal_embryo_size | 1.27496868 |
| 72 | MP0004215_abnormal_myocardial_fiber | 1.25003000 |
| 73 | MP0005623_abnormal_meninges_morphology | 1.23580038 |
| 74 | MP0001915_intracranial_hemorrhage | 1.23466902 |
| 75 | MP0002085_abnormal_embryonic_tissue | 1.20802788 |
| 76 | * MP0000598_abnormal_liver_morphology | 1.19714340 |
| 77 | MP0002092_abnormal_eye_morphology | 1.19430219 |
| 78 | MP0009643_abnormal_urine_homeostasis | 1.18542523 |
| 79 | MP0003656_abnormal_erythrocyte_physiolo | 1.17656648 |
| 80 | MP0000350_abnormal_cell_proliferation | 1.15070518 |
| 81 | MP0002086_abnormal_extraembryonic_tissu | 1.15062648 |
| 82 | MP0004197_abnormal_fetal_growth/weight/ | 1.14018834 |
| 83 | MP0003861_abnormal_nervous_system | 1.13441035 |
| 84 | MP0009764_decreased_sensitivity_to | 1.11789230 |
| 85 | MP0009703_decreased_birth_body | 1.11706554 |
| 86 | MP0004084_abnormal_cardiac_muscle | 1.10957718 |
| 87 | MP0000428_abnormal_craniofacial_morphol | 1.10397477 |
| 88 | MP0002751_abnormal_autonomic_nervous | 1.07344550 |
| 89 | MP0003935_abnormal_craniofacial_develop | 1.06000173 |
| 90 | MP0002111_abnormal_tail_morphology | 1.05533812 |
| 91 | MP0008438_abnormal_cutaneous_collagen | 1.04404118 |
| 92 | MP0009046_muscle_twitch | 1.02851572 |
| 93 | MP0008775_abnormal_heart_ventricle | 1.01160926 |
| 94 | MP0000358_abnormal_cell_content/ | 1.00641737 |
| 95 | MP0005647_abnormal_sex_gland | 0.99142646 |
| 96 | MP0002080_prenatal_lethality | 0.98684024 |
| 97 | MP0005253_abnormal_eye_physiology | 0.98182822 |
| 98 | MP0005391_vision/eye_phenotype | 0.98141388 |
| 99 | MP0003119_abnormal_digestive_system | 0.96507626 |
| 100 | MP0005408_hypopigmentation | 0.96471000 |
| 101 | MP0005171_absent_coat_pigmentation | 0.95549005 |
| 102 | MP0009763_increased_sensitivity_to | 0.95528765 |
| 103 | MP0005464_abnormal_platelet_physiology | 0.95407255 |
| 104 | MP0005084_abnormal_gallbladder_morpholo | 0.95343350 |
| 105 | MP0003880_abnormal_central_pattern | 0.95029519 |
| 106 | MP0003186_abnormal_redox_activity | 0.94951390 |
| 107 | MP0004742_abnormal_vestibular_system | 0.94773794 |
| 108 | MP0000534_abnormal_ureter_morphology | 0.91702791 |
| 109 | MP0003942_abnormal_urinary_system | 0.91040904 |
| 110 | MP0009765_abnormal_xenobiotic_induced | 0.90938007 |
| 111 | MP0000604_amyloidosis | 0.89710213 |
| 112 | MP0003011_delayed_dark_adaptation | 0.89582558 |
| 113 | MP0002184_abnormal_innervation | 0.89271694 |
| 114 | MP0006035_abnormal_mitochondrial_morpho | 0.88980088 |
| 115 | MP0005257_abnormal_intraocular_pressure | 0.88750179 |
| 116 | MP0000432_abnormal_head_morphology | 0.87291213 |
| 117 | MP0002234_abnormal_pharynx_morphology | 0.86902342 |
| 118 | MP0003566_abnormal_cell_adhesion | 0.86432386 |
| 119 | MP0003300_gastrointestinal_ulcer | 0.86221074 |
| 120 | MP0002006_tumorigenesis | 0.86143824 |
| 121 | MP0004270_analgesia | 0.85870649 |
| 122 | MP0010307_abnormal_tumor_latency | 0.85034511 |
| 123 | MP0004947_skin_inflammation | 0.84065799 |
| 124 | MP0008469_abnormal_protein_level | 0.83859938 |
| 125 | MP0002090_abnormal_vision | 0.83806957 |
| 126 | MP0008789_abnormal_olfactory_epithelium | 0.83730623 |
| 127 | MP0004264_abnormal_extraembryonic_tissu | 0.83162481 |
| 128 | MP0002081_perinatal_lethality | 0.82977540 |
| 129 | MP0001340_abnormal_eyelid_morphology | 0.82381839 |
| 130 | MP0008877_abnormal_DNA_methylation | 0.81416537 |
| 131 | MP0005636_abnormal_mineral_homeostasis | 0.80752759 |
| 132 | MP0001879_abnormal_lymphatic_vessel | 0.80648442 |
| 133 | MP0005220_abnormal_exocrine_pancreas | 0.79587730 |
| 134 | MP0002152_abnormal_brain_morphology | 0.77386751 |
| 135 | MP0005501_abnormal_skin_physiology | 0.77154390 |
| 136 | MP0005197_abnormal_uvea_morphology | 0.76901364 |
| 137 | * MP0009642_abnormal_blood_homeostasis | 0.75850804 |
| 138 | MP0005187_abnormal_penis_morphology | 0.74228801 |
| 139 | MP0004811_abnormal_neuron_physiology | 0.73609307 |
| 140 | MP0002925_abnormal_cardiovascular_devel | 0.72474190 |
| 141 | MP0004859_abnormal_synaptic_plasticity | 0.72219716 |
| 142 | MP0003453_abnormal_keratinocyte_physiol | 0.71598148 |
| 143 | MP0002060_abnormal_skin_morphology | 0.69281148 |
| 144 | MP0009053_abnormal_anal_canal | 0.69185836 |
| 145 | MP0001243_abnormal_dermal_layer | 0.66588656 |
| 146 | MP0002254_reproductive_system_inflammat | 0.65565971 |
| 147 | MP0002876_abnormal_thyroid_physiology | 0.62214878 |
| 148 | MP0001216_abnormal_epidermal_layer | 0.61789955 |
| 149 | MP0003638_abnormal_response/metabolism_ | 0.61014495 |
| 150 | MP0003436_decreased_susceptibility_to | 0.59110103 |
| 151 | MP0008873_increased_physiological_sensi | 0.57369979 |
| 152 | MP0010352_gastrointestinal_tract_polyps | 0.57200099 |
| 153 | MP0005376_homeostasis/metabolism_phenot | 0.56995606 |
| 154 | MP0009384_cardiac_valve_regurgitation | 0.56320755 |
| 155 | MP0004782_abnormal_surfactant_physiolog | 0.56232513 |
| 156 | MP0003724_increased_susceptibility_to | 0.55858613 |
| 157 | MP0004147_increased_porphyrin_level | 0.54864846 |
| 158 | MP0005167_abnormal_blood-brain_barrier | 0.54501331 |
| 159 | MP0005334_abnormal_fat_pad | 0.53483430 |
| 160 | MP0002971_abnormal_brown_adipose | 0.53439738 |
| 161 | MP0009931_abnormal_skin_appearance | 0.51710597 |
| 162 | MP0009379_abnormal_foot_pigmentation | 0.51159652 |
| 163 | MP0000465_gastrointestinal_hemorrhage | 0.51155072 |
| 164 | MP0002098_abnormal_vibrissa_morphology | 0.50872102 |
| 165 | MP0000647_abnormal_sebaceous_gland | 0.49567561 |
| 166 | MP0000579_abnormal_nail_morphology | 0.49468390 |
| 167 | MP0002136_abnormal_kidney_physiology | 0.48987789 |
| 168 | MP0000377_abnormal_hair_follicle | 0.48942148 |
| 169 | MP0000639_abnormal_adrenal_gland | 0.48313560 |
| 170 | MP0010155_abnormal_intestine_physiology | 0.48242285 |
| 171 | MP0001191_abnormal_skin_condition | 0.48058465 |
| 172 | MP0000427_abnormal_hair_cycle | 0.48028135 |
| 173 | MP0003329_amyloid_beta_deposits | 0.47640707 |
| 174 | MP0002078_abnormal_glucose_homeostasis | 0.46592049 |
| 175 | MP0001756_abnormal_urination | 0.46023909 |
| 176 | MP0002928_abnormal_bile_duct | 0.44834881 |
| 177 | MP0001661_extended_life_span | 0.44530314 |
| 178 | MP0005448_abnormal_energy_balance | 0.44369035 |
| 179 | MP0005023_abnormal_wound_healing | 0.42797393 |
| 180 | MP0000249_abnormal_blood_vessel | 0.42299389 |
| 181 | MP0003690_abnormal_glial_cell | 0.41814849 |
| 182 | MP0001845_abnormal_inflammatory_respons | 0.41586959 |
| 183 | MP0005266_abnormal_metabolism | 0.40066670 |
| 184 | MP0002877_abnormal_melanocyte_morpholog | 0.40008146 |
| 185 | MP0004381_abnormal_hair_follicle | 0.38825988 |
| 186 | MP0003718_maternal_effect | 0.38619385 |
| 187 | MP0006054_spinal_hemorrhage | 0.38423160 |
| 188 | MP0005395_other_phenotype | 0.38262599 |
| 189 | MP0010678_abnormal_skin_adnexa | 0.38065868 |
| 190 | MP0000477_abnormal_intestine_morphology | 0.38031572 |
| 191 | MP0009672_abnormal_birth_weight | 0.37326538 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.43750595 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.20711405 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.80630737 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.65032088 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.48593514 |
| 6 | Xanthomatosis (HP:0000991) | 6.06510403 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 6.01526255 |
| 8 | Epidermoid cyst (HP:0200040) | 4.86636012 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.69513900 |
| 10 | Abnormality of the common coagulation pathway (HP:0010990) | 4.47843717 |
| 11 | Complement deficiency (HP:0004431) | 4.47177071 |
| 12 | Joint hemorrhage (HP:0005261) | 4.46453246 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.46221421 |
| 14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.41082912 |
| 15 | Fat malabsorption (HP:0002630) | 4.28143745 |
| 16 | Cortical dysplasia (HP:0002539) | 4.23428792 |
| 17 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.10427028 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.99955349 |
| 19 | Hyperammonemia (HP:0001987) | 3.99585030 |
| 20 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.95010364 |
| 21 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.89550958 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 3.89215301 |
| 23 | Conjugated hyperbilirubinemia (HP:0002908) | 3.81708820 |
| 24 | Hyperglycinemia (HP:0002154) | 3.73543153 |
| 25 | Abnormality of the intrinsic pathway (HP:0010989) | 3.68613468 |
| 26 | Acanthocytosis (HP:0001927) | 3.59595544 |
| 27 | Abnormality of glycolysis (HP:0004366) | 3.59391696 |
| 28 | Ketosis (HP:0001946) | 3.51247824 |
| 29 | Increased serum pyruvate (HP:0003542) | 3.50023732 |
| 30 | Hypercholesterolemia (HP:0003124) | 3.49443413 |
| 31 | Hypoalphalipoproteinemia (HP:0003233) | 3.45988266 |
| 32 | Abnormality of complement system (HP:0005339) | 3.27949716 |
| 33 | Hyperbilirubinemia (HP:0002904) | 3.26495178 |
| 34 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.24707171 |
| 35 | Abnormality of glycine metabolism (HP:0010895) | 3.24707171 |
| 36 | Hypoglycemic coma (HP:0001325) | 3.22961126 |
| 37 | Termporal pattern (HP:0011008) | 3.15093328 |
| 38 | Insidious onset (HP:0003587) | 3.15093328 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.13154205 |
| 40 | Scanning speech (HP:0002168) | 3.10976824 |
| 41 | Steatorrhea (HP:0002570) | 3.09737635 |
| 42 | Spontaneous abortion (HP:0005268) | 3.01365958 |
| 43 | Atonic seizures (HP:0010819) | 3.00668267 |
| 44 | Hypochromic microcytic anemia (HP:0004840) | 2.98282287 |
| 45 | Abnormal lung lobation (HP:0002101) | 2.97694166 |
| 46 | Hyperglycinuria (HP:0003108) | 2.96077112 |
| 47 | Hepatocellular carcinoma (HP:0001402) | 2.95798912 |
| 48 | Abnormality of nucleobase metabolism (HP:0010932) | 2.95630390 |
| 49 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.91776486 |
| 50 | Myocardial infarction (HP:0001658) | 2.90807089 |
| 51 | Papillary thyroid carcinoma (HP:0002895) | 2.73160128 |
| 52 | Increased nuchal translucency (HP:0010880) | 2.70756372 |
| 53 | Vascular calcification (HP:0004934) | 2.69338213 |
| 54 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.68053180 |
| 55 | Hypoplastic pelvis (HP:0008839) | 2.66039353 |
| 56 | Supernumerary spleens (HP:0009799) | 2.65427126 |
| 57 | Gingival bleeding (HP:0000225) | 2.64969775 |
| 58 | Skin nodule (HP:0200036) | 2.62449935 |
| 59 | Malnutrition (HP:0004395) | 2.57791522 |
| 60 | Overlapping toe (HP:0001845) | 2.57771509 |
| 61 | Hemorrhage of the eye (HP:0011885) | 2.56432335 |
| 62 | Esophageal varix (HP:0002040) | 2.54723949 |
| 63 | Poikilocytosis (HP:0004447) | 2.53941568 |
| 64 | Abnormality of serum amino acid levels (HP:0003112) | 2.53083705 |
| 65 | Spastic diplegia (HP:0001264) | 2.51003560 |
| 66 | Increased mean platelet volume (HP:0011877) | 2.50046139 |
| 67 | Abnormality of purine metabolism (HP:0004352) | 2.48670106 |
| 68 | Thyroid carcinoma (HP:0002890) | 2.48307065 |
| 69 | Colon cancer (HP:0003003) | 2.46745078 |
| 70 | Menorrhagia (HP:0000132) | 2.46231447 |
| 71 | Abnormality of the labia minora (HP:0012880) | 2.44809348 |
| 72 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.44492435 |
| 73 | Ketoacidosis (HP:0001993) | 2.43677152 |
| 74 | Cardiovascular calcification (HP:0011915) | 2.42334102 |
| 75 | Medulloblastoma (HP:0002885) | 2.38819716 |
| 76 | Action tremor (HP:0002345) | 2.38557384 |
| 77 | Embryonal renal neoplasm (HP:0011794) | 2.38374330 |
| 78 | Abnormal cartilage morphology (HP:0002763) | 2.37154887 |
| 79 | Mitral stenosis (HP:0001718) | 2.36181228 |
| 80 | Hepatoblastoma (HP:0002884) | 2.35836996 |
| 81 | Metabolic acidosis (HP:0001942) | 2.32623731 |
| 82 | Abnormality of chromosome stability (HP:0003220) | 2.31979792 |
| 83 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.27328936 |
| 84 | Rhabdomyosarcoma (HP:0002859) | 2.26474842 |
| 85 | Abnormal platelet volume (HP:0011876) | 2.25041593 |
| 86 | Abnormality of the lower motor neuron (HP:0002366) | 2.24605381 |
| 87 | Bifid tongue (HP:0010297) | 2.22034819 |
| 88 | Pheochromocytoma (HP:0002666) | 2.21341817 |
| 89 | Thrombophlebitis (HP:0004418) | 2.20328576 |
| 90 | Bladder carcinoma (HP:0002862) | 2.17713712 |
| 91 | Bladder neoplasm (HP:0009725) | 2.17713712 |
| 92 | Abnormal gallbladder morphology (HP:0012437) | 2.17111047 |
| 93 | Generalized hypotonia (HP:0001290) | 2.14699622 |
| 94 | Abnormal gallbladder physiology (HP:0012438) | 2.14073338 |
| 95 | Cholecystitis (HP:0001082) | 2.14073338 |
| 96 | Uterine leiomyosarcoma (HP:0002891) | 2.13764988 |
| 97 | Leiomyosarcoma (HP:0100243) | 2.13764988 |
| 98 | Volvulus (HP:0002580) | 2.12402691 |
| 99 | Hypoglycemic seizures (HP:0002173) | 2.11319333 |
| 100 | Abnormal tarsal ossification (HP:0008369) | 2.09926672 |
| 101 | Vertebral arch anomaly (HP:0008438) | 2.09467181 |
| 102 | Rickets (HP:0002748) | 2.08722662 |
| 103 | Meckel diverticulum (HP:0002245) | 2.06974274 |
| 104 | Neonatal onset (HP:0003623) | 2.06193570 |
| 105 | Myelomeningocele (HP:0002475) | 2.04377340 |
| 106 | Short humerus (HP:0005792) | 2.04172917 |
| 107 | Curly hair (HP:0002212) | 2.03532051 |
| 108 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.03084273 |
| 109 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.02303680 |
| 110 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.01875003 |
| 111 | Cholelithiasis (HP:0001081) | 2.01718593 |
| 112 | Broad foot (HP:0001769) | 2.01652213 |
| 113 | Irritability (HP:0000737) | 2.01301012 |
| 114 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.01260116 |
| 115 | Dicarboxylic aciduria (HP:0003215) | 2.01260116 |
| 116 | Abnormality of proline metabolism (HP:0010907) | 2.01092652 |
| 117 | Hydroxyprolinuria (HP:0003080) | 2.01092652 |
| 118 | Chromsome breakage (HP:0040012) | 1.99021131 |
| 119 | High anterior hairline (HP:0009890) | 1.97670084 |
| 120 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.97643874 |
| 121 | Gastrointestinal carcinoma (HP:0002672) | 1.97643874 |
| 122 | Duodenal stenosis (HP:0100867) | 1.97221811 |
| 123 | Small intestinal stenosis (HP:0012848) | 1.97221811 |
| 124 | Abnormality of iron homeostasis (HP:0011031) | 1.97151541 |
| 125 | Abnormality of the ileum (HP:0001549) | 1.96185077 |
| 126 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.96139430 |
| 127 | Pancreatitis (HP:0001733) | 1.95799182 |
| 128 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.95671796 |
| 129 | Systemic lupus erythematosus (HP:0002725) | 1.95489713 |
| 130 | Abnormality of vitamin metabolism (HP:0100508) | 1.95357731 |
| 131 | Late onset (HP:0003584) | 1.93673078 |
| 132 | Abnormal auditory evoked potentials (HP:0006958) | 1.91878494 |
| 133 | Facial hemangioma (HP:0000329) | 1.91368610 |
| 134 | Reticulocytosis (HP:0001923) | 1.90906221 |
| 135 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.90526727 |
| 136 | Exotropia (HP:0000577) | 1.90471262 |
| 137 | Hypophosphatemic rickets (HP:0004912) | 1.89876721 |
| 138 | Abnormality of the Achilles tendon (HP:0005109) | 1.89597204 |
| 139 | Postnatal microcephaly (HP:0005484) | 1.89403316 |
| 140 | Large earlobe (HP:0009748) | 1.88848537 |
| 141 | Glomerulonephritis (HP:0000099) | 1.87908096 |
| 142 | Lethargy (HP:0001254) | 1.87636689 |
| 143 | Gout (HP:0001997) | 1.87316227 |
| 144 | Alkalosis (HP:0001948) | 1.87107620 |
| 145 | Deviation of the thumb (HP:0009603) | 1.86975766 |
| 146 | Amyloidosis (HP:0011034) | 1.85867807 |
| 147 | Abnormality of the gallbladder (HP:0005264) | 1.85831993 |
| 148 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.85051803 |
| 149 | Protuberant abdomen (HP:0001538) | 1.84175143 |
| 150 | Neuroendocrine neoplasm (HP:0100634) | 1.84073768 |
| 151 | Proximal placement of thumb (HP:0009623) | 1.83982071 |
| 152 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.82451154 |
| 153 | Drooling (HP:0002307) | 1.81093443 |
| 154 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.80861230 |
| 155 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.80861230 |
| 156 | Ankyloglossia (HP:0010296) | 1.79607806 |
| 157 | Abnormality of the duodenum (HP:0002246) | 1.79033332 |
| 158 | Ileus (HP:0002595) | 1.78783585 |
| 159 | Abnormality of oral frenula (HP:0000190) | 1.78016740 |
| 160 | Abnormality of the anterior horn cell (HP:0006802) | 1.76639316 |
| 161 | Degeneration of anterior horn cells (HP:0002398) | 1.76639316 |
| 162 | Polycythemia (HP:0001901) | 1.76380534 |
| 163 | Pulmonary embolism (HP:0002204) | 1.75875094 |
| 164 | Epistaxis (HP:0000421) | 1.75790835 |
| 165 | Broad palm (HP:0001169) | 1.75685434 |
| 166 | Enlarged kidneys (HP:0000105) | 1.73444012 |
| 167 | Opisthotonus (HP:0002179) | 1.71247525 |
| 168 | Arterial tortuosity (HP:0005116) | 1.70511822 |
| 169 | Joint swelling (HP:0001386) | 1.69928421 |
| 170 | Hammertoe (HP:0001765) | 1.69923719 |
| 171 | Tetraparesis (HP:0002273) | 1.68708883 |
| 172 | Premature rupture of membranes (HP:0001788) | 1.68448144 |
| 173 | Febrile seizures (HP:0002373) | 1.68237050 |
| 174 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.67197164 |
| 175 | Trigonocephaly (HP:0000243) | 1.67047163 |
| 176 | Shoulder girdle muscle weakness (HP:0003547) | 1.65612194 |
| 177 | Exercise-induced muscle cramps (HP:0003710) | 1.62021258 |
| 178 | Intestinal atresia (HP:0011100) | 1.61171832 |
| 179 | Fibular aplasia (HP:0002990) | 1.61159220 |
| 180 | Ovarian neoplasm (HP:0100615) | 1.60283364 |
| 181 | Omphalocele (HP:0001539) | 1.56634782 |
| 182 | Pulmonic stenosis (HP:0001642) | 1.56266887 |
| 183 | Focal motor seizures (HP:0011153) | 1.56264354 |
| 184 | Micropenis (HP:0000054) | 1.56025296 |
| 185 | Scrotal hypoplasia (HP:0000046) | 1.55617922 |
| 186 | Vertebral hypoplasia (HP:0008417) | 1.54805985 |
| 187 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.54805985 |
| 188 | Relative macrocephaly (HP:0004482) | 1.54772449 |
| 189 | Glioma (HP:0009733) | 1.54743407 |
| 190 | Heterotopia (HP:0002282) | 1.54307974 |
| 191 | 2-3 toe syndactyly (HP:0004691) | 1.53777413 |
| 192 | Uterine neoplasm (HP:0010784) | 1.53540797 |
| 193 | Abnormality of the corticospinal tract (HP:0002492) | 1.53312161 |
| 194 | Intestinal polyposis (HP:0200008) | 1.53218073 |
| 195 | Sloping forehead (HP:0000340) | 1.53142317 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PKN2 | 3.59536640 |
| 2 | SIK1 | 3.48667422 |
| 3 | NEK9 | 3.46529946 |
| 4 | NEK1 | 3.45003746 |
| 5 | BCKDK | 3.39920053 |
| 6 | FGFR4 | 3.34475477 |
| 7 | TSSK6 | 3.27820209 |
| 8 | SRPK1 | 3.15178902 |
| 9 | BCR | 3.05181711 |
| 10 | EIF2AK3 | 3.03478207 |
| 11 | TNIK | 2.98081164 |
| 12 | ERN1 | 2.93608326 |
| 13 | MST1R | 2.86700420 |
| 14 | TAOK3 | 2.62152298 |
| 15 | TTK | 2.61386846 |
| 16 | FLT3 | 2.37072522 |
| 17 | MKNK1 | 2.34829073 |
| 18 | ERBB4 | 2.32914368 |
| 19 | FRK | 2.27986635 |
| 20 | BRD4 | 2.26852635 |
| 21 | MKNK2 | 2.24638209 |
| 22 | PTK6 | 2.17303502 |
| 23 | PLK4 | 2.14445946 |
| 24 | BUB1 | 2.09038610 |
| 25 | WEE1 | 1.95474577 |
| 26 | TRIM28 | 1.90006818 |
| 27 | TRIB3 | 1.86491357 |
| 28 | PLK3 | 1.83953101 |
| 29 | EIF2AK1 | 1.76786200 |
| 30 | MST4 | 1.75488710 |
| 31 | LATS1 | 1.75085824 |
| 32 | MAP3K4 | 1.74832162 |
| 33 | EEF2K | 1.74808939 |
| 34 | RIPK1 | 1.74320610 |
| 35 | PLK2 | 1.73186446 |
| 36 | BRSK2 | 1.67390937 |
| 37 | CDK6 | 1.60299543 |
| 38 | STK38L | 1.57849227 |
| 39 | MET | 1.56346840 |
| 40 | KDR | 1.54827930 |
| 41 | NTRK1 | 1.45919742 |
| 42 | FGFR2 | 1.44141840 |
| 43 | MAPK11 | 1.43318119 |
| 44 | TGFBR1 | 1.43300122 |
| 45 | YES1 | 1.42872127 |
| 46 | EPHB1 | 1.39986396 |
| 47 | CDC7 | 1.36522164 |
| 48 | ACVR1B | 1.36412086 |
| 49 | MAP3K10 | 1.33759722 |
| 50 | LATS2 | 1.31382284 |
| 51 | PNCK | 1.31341137 |
| 52 | ERBB3 | 1.30762960 |
| 53 | TIE1 | 1.29845346 |
| 54 | MAP3K14 | 1.28287011 |
| 55 | STK24 | 1.24073406 |
| 56 | MAP3K3 | 1.24030042 |
| 57 | TBK1 | 1.23308933 |
| 58 | INSRR | 1.22274065 |
| 59 | GRK6 | 1.21649080 |
| 60 | MAP3K2 | 1.19758628 |
| 61 | EPHB2 | 1.17750592 |
| 62 | CSK | 1.17582159 |
| 63 | RPS6KA4 | 1.17488488 |
| 64 | STK3 | 1.16750300 |
| 65 | ERBB2 | 1.16472546 |
| 66 | MAP4K1 | 1.16414984 |
| 67 | PRKG2 | 1.16360318 |
| 68 | TYK2 | 1.13176563 |
| 69 | ABL2 | 1.09376719 |
| 70 | LRRK2 | 1.09088918 |
| 71 | CSNK1A1L | 1.07061542 |
| 72 | IRAK3 | 1.05335561 |
| 73 | MAP3K7 | 1.04832729 |
| 74 | JAK2 | 1.04722955 |
| 75 | MAP2K2 | 1.04558710 |
| 76 | MAP3K11 | 1.02178810 |
| 77 | WNK3 | 0.98314693 |
| 78 | CASK | 0.97331170 |
| 79 | NEK2 | 0.97069771 |
| 80 | TAF1 | 0.96682026 |
| 81 | PLK1 | 0.96042134 |
| 82 | CSNK1G1 | 0.94128281 |
| 83 | KSR1 | 0.90827062 |
| 84 | PIK3CG | 0.89709238 |
| 85 | DYRK1B | 0.89203671 |
| 86 | MAP2K3 | 0.88201166 |
| 87 | STK10 | 0.88136888 |
| 88 | EPHA3 | 0.87449297 |
| 89 | EIF2AK2 | 0.87240161 |
| 90 | ZAK | 0.86660818 |
| 91 | CSNK1G3 | 0.85937137 |
| 92 | MAP2K7 | 0.85843079 |
| 93 | MAP2K4 | 0.84835493 |
| 94 | JAK3 | 0.84618542 |
| 95 | PTK2 | 0.79941462 |
| 96 | PINK1 | 0.79166968 |
| 97 | RET | 0.78989789 |
| 98 | BMPR1B | 0.78221909 |
| 99 | FGFR3 | 0.76859604 |
| 100 | CSNK1G2 | 0.75937653 |
| 101 | MAPK4 | 0.72260331 |
| 102 | JAK1 | 0.72021093 |
| 103 | ROCK2 | 0.71776492 |
| 104 | MAP3K8 | 0.68350371 |
| 105 | CHEK2 | 0.66999827 |
| 106 | RPS6KB2 | 0.66481811 |
| 107 | CLK1 | 0.66340012 |
| 108 | PRKAA2 | 0.64507939 |
| 109 | PAK4 | 0.63850178 |
| 110 | CAMKK2 | 0.63521682 |
| 111 | ATM | 0.63440457 |
| 112 | MATK | 0.62477878 |
| 113 | CDK4 | 0.61996944 |
| 114 | MINK1 | 0.60562090 |
| 115 | PIM1 | 0.59846934 |
| 116 | PRKCQ | 0.59012483 |
| 117 | MAP2K6 | 0.58483405 |
| 118 | TRPM7 | 0.58183505 |
| 119 | IKBKE | 0.57971555 |
| 120 | CDK18 | 0.57595814 |
| 121 | SCYL2 | 0.56338655 |
| 122 | GSK3A | 0.56038625 |
| 123 | MARK1 | 0.55240360 |
| 124 | MAP3K12 | 0.55227377 |
| 125 | ALK | 0.54781449 |
| 126 | EPHA4 | 0.54694928 |
| 127 | PIK3CA | 0.53787142 |
| 128 | BRSK1 | 0.53158694 |
| 129 | ATR | 0.52913221 |
| 130 | NTRK2 | 0.52344338 |
| 131 | CDK14 | 0.52165995 |
| 132 | PRKCZ | 0.51734533 |
| 133 | PDGFRB | 0.51093905 |
| 134 | MOS | 0.50288889 |
| 135 | CDK3 | 0.49960391 |
| 136 | FGFR1 | 0.49610290 |
| 137 | CHUK | 0.49119088 |
| 138 | MTOR | 0.48191782 |
| 139 | CDK15 | 0.47999891 |
| 140 | IKBKB | 0.47880776 |
| 141 | STK39 | 0.47765005 |
| 142 | CCNB1 | 0.47758546 |
| 143 | IGF1R | 0.47060495 |
| 144 | NUAK1 | 0.46930562 |
| 145 | PDGFRA | 0.45516337 |
| 146 | PRKACG | 0.45072761 |
| 147 | CHEK1 | 0.44578595 |
| 148 | MAP3K1 | 0.44379371 |
| 149 | CDK11A | 0.44182555 |
| 150 | EGFR | 0.43556028 |
| 151 | RAF1 | 0.42403108 |
| 152 | SIK3 | 0.42239145 |
| 153 | BTK | 0.41532679 |
| 154 | PBK | 0.40895012 |
| 155 | ITK | 0.40108148 |
| 156 | DYRK3 | 0.39330458 |
| 157 | TYRO3 | 0.38925498 |
| 158 | CDK1 | 0.38107030 |
| 159 | CAMK1D | 0.37889761 |
| 160 | MAP3K5 | 0.37736832 |
| 161 | MAP2K1 | 0.37682896 |
| 162 | AURKB | 0.36655010 |
| 163 | PASK | 0.36266708 |
| 164 | CSF1R | 0.36060301 |
| 165 | MELK | 0.35511736 |
| 166 | PRKCG | 0.34624774 |
| 167 | VRK1 | 0.34064218 |
| 168 | EPHA2 | 0.33628084 |
| 169 | PRKCE | 0.33421313 |
| 170 | ZAP70 | 0.32823033 |
| 171 | PAK2 | 0.32346449 |
| 172 | PDPK1 | 0.32318235 |
| 173 | ABL1 | 0.29953054 |
| 174 | GRK1 | 0.29940709 |
| 175 | CSNK1D | 0.29817668 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.36627294 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.69079216 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.48337627 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.87767353 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.83371109 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.77430905 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.75272609 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.61549176 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.55592760 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.41107235 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.39424768 |
| 12 | Protein export_Homo sapiens_hsa03060 | 2.34191105 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.32441045 |
| 14 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.26272473 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.21069941 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.19241808 |
| 17 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.18485416 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.15231473 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 2.05652946 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.98739618 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.96211400 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.92090172 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.91287842 |
| 24 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.89645049 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.87459383 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.84107782 |
| 27 | Cell cycle_Homo sapiens_hsa04110 | 1.83118581 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.81097939 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.77727281 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.73705707 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.70766006 |
| 32 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.68434788 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.66945760 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.66521319 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.63450778 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.60431311 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.58856623 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.54935354 |
| 39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.50121926 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.48372439 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.40767599 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36842871 |
| 43 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.36441963 |
| 44 | RNA transport_Homo sapiens_hsa03013 | 1.33769132 |
| 45 | Adherens junction_Homo sapiens_hsa04520 | 1.29347980 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.28848294 |
| 47 | RNA degradation_Homo sapiens_hsa03018 | 1.28384142 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.27680453 |
| 49 | Mismatch repair_Homo sapiens_hsa03430 | 1.26477843 |
| 50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.24553398 |
| 51 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.24104497 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 1.22740688 |
| 53 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.21850317 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.20648753 |
| 55 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.20241085 |
| 56 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.19721858 |
| 57 | Basal transcription factors_Homo sapiens_hsa03022 | 1.19401727 |
| 58 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.16693617 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 1.15544362 |
| 60 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.13346416 |
| 61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.10495600 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.04405871 |
| 63 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.01177914 |
| 64 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.00722498 |
| 65 | Spliceosome_Homo sapiens_hsa03040 | 0.98981562 |
| 66 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.97926627 |
| 67 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.96864478 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94789589 |
| 69 | Carbon metabolism_Homo sapiens_hsa01200 | 0.93811762 |
| 70 | GABAergic synapse_Homo sapiens_hsa04727 | 0.91357434 |
| 71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90884371 |
| 72 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.89573800 |
| 73 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.88793214 |
| 74 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.87847968 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 0.87721006 |
| 76 | Nicotine addiction_Homo sapiens_hsa05033 | 0.87478334 |
| 77 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.85177744 |
| 78 | Long-term depression_Homo sapiens_hsa04730 | 0.84207842 |
| 79 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.83787143 |
| 80 | Colorectal cancer_Homo sapiens_hsa05210 | 0.83113924 |
| 81 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.81160831 |
| 82 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.78465266 |
| 83 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.78332925 |
| 84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.76094847 |
| 85 | Axon guidance_Homo sapiens_hsa04360 | 0.75159992 |
| 86 | Gap junction_Homo sapiens_hsa04540 | 0.75087937 |
| 87 | DNA replication_Homo sapiens_hsa03030 | 0.74058932 |
| 88 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70929285 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70421611 |
| 90 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.70104547 |
| 91 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.69597932 |
| 92 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.67893259 |
| 93 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67661553 |
| 94 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.64545744 |
| 95 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.60997473 |
| 96 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60834501 |
| 97 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.60691404 |
| 98 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.59257337 |
| 99 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57875209 |
| 100 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56912278 |
| 101 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.53403911 |
| 102 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52561385 |
| 103 | Alcoholism_Homo sapiens_hsa05034 | 0.52374289 |
| 104 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.51969068 |
| 105 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.51575517 |
| 106 | Tight junction_Homo sapiens_hsa04530 | 0.48257700 |
| 107 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46595608 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45290549 |
| 109 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.44589960 |
| 110 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.43677841 |
| 111 | Focal adhesion_Homo sapiens_hsa04510 | 0.40778454 |
| 112 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.40391596 |
| 113 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.39251841 |
| 114 | Circadian rhythm_Homo sapiens_hsa04710 | 0.37949857 |
| 115 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.37877849 |
| 116 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35668984 |
| 117 | Pathways in cancer_Homo sapiens_hsa05200 | 0.34855213 |
| 118 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.34562079 |
| 119 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.34517063 |
| 120 | Homologous recombination_Homo sapiens_hsa03440 | 0.33686408 |
| 121 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.33609640 |
| 122 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.33208578 |
| 123 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.32509198 |
| 124 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.31630895 |
| 125 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.29444366 |
| 126 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29396232 |
| 127 | Prostate cancer_Homo sapiens_hsa05215 | 0.28019028 |
| 128 | Endometrial cancer_Homo sapiens_hsa05213 | 0.27920136 |
| 129 | Long-term potentiation_Homo sapiens_hsa04720 | 0.26656203 |
| 130 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.26156492 |
| 131 | Morphine addiction_Homo sapiens_hsa05032 | 0.25982506 |
| 132 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.24470668 |
| 133 | Insulin resistance_Homo sapiens_hsa04931 | 0.24370988 |
| 134 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22038971 |
| 135 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.18782531 |
| 136 | Prion diseases_Homo sapiens_hsa05020 | 0.17857583 |
| 137 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.11499249 |
| 138 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.08001024 |
| 139 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.06026864 |
| 140 | Hepatitis C_Homo sapiens_hsa05160 | 0.05404974 |
| 141 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02841914 |
| 142 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.01815949 |
| 143 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1702794 |
| 144 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.1702563 |
| 145 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1669006 |
| 146 | Thyroid cancer_Homo sapiens_hsa05216 | -0.1618991 |
| 147 | Legionellosis_Homo sapiens_hsa05134 | -0.1588258 |
| 148 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1497322 |
| 149 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1389930 |
| 150 | Amoebiasis_Homo sapiens_hsa05146 | -0.1380181 |
| 151 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1340549 |
| 152 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1296987 |
| 153 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1205994 |
| 154 | Pertussis_Homo sapiens_hsa05133 | -0.0973091 |
| 155 | Bladder cancer_Homo sapiens_hsa05219 | -0.0846925 |
| 156 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0768421 |
| 157 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0662927 |
| 158 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0643470 |
| 159 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | -0.0523196 |
| 160 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0412428 |
| 161 | Mineral absorption_Homo sapiens_hsa04978 | -0.0223771 |

